Aptose Biosciences Inc. (APS.TO)

CAD 0.27

(0.0%)

Revenue Summary of Aptose Biosciences Inc.

  • Aptose Biosciences Inc.'s latest annual revenue in 2023 was - USD , down 0.0% from previous year.
  • Aptose Biosciences Inc.'s latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Aptose Biosciences Inc. reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • Aptose Biosciences Inc. reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • Aptose Biosciences Inc. reported a quarterly revenue of - USD for 2024 Q2, down 0.0% from previous quarter.
  • Aptose Biosciences Inc. reported a quarterly revenue of - USD for 2023 FY, down 0.0% from previous quarter.

Annual Revenue Chart of Aptose Biosciences Inc. (2023 - 1996)

Historical Annual Revenue of Aptose Biosciences Inc. (2023 - 1996)

Year Revenue Revenue Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD -100.0%
2009 124.15 Thousand USD -26.45%
2008 168.8 Thousand USD 292.36%
2007 43.02 Thousand USD -56.99%
2006 100.02 Thousand USD 316.76%
2005 24 Thousand USD 380.1%
2004 4998.96 USD -98.88%
2003 446.69 Thousand USD 834.08%
2002 47.82 Thousand USD 0.0%
2001 - USD -100.0%
2000 1000.31 USD 49.88%
1999 667.40 USD -99.02%
1998 67.82 Thousand USD -1.21%
1997 68.65 Thousand USD -5.38%
1996 72.55 Thousand USD 0.0%

Peer Revenue Comparison of Aptose Biosciences Inc.

Name Revenue Revenue Difference
Appili Therapeutics Inc. 827.4 Thousand CAD 100.0%
Eupraxia Pharmaceuticals Inc. - CAD NaN%
Helix BioPharma Corp. - CAD NaN%
Microbix Biosystems Inc. 16.51 Million CAD 100.0%
Medicenna Therapeutics Corp. - CAD NaN%
Satellos Bioscience Inc. - CAD NaN%
Oncolytics Biotech Inc. - CAD NaN%
Sernova Corp. - CAD NaN%